Skip to main content

Advertisement

SpringerLink
Log in

Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

The level of 67 kDa laminin receptor (67LR) expression on breast and colon tumor cell surfaces was previously shown to be correlated with the capacity of tumor cells to metastasize. In the present work we investigate the effects of progestins and estrogen on the expression of 67LR in two sublines of the T47D human breast cancer cells: weakly tumorigenic, poorly invasive parental T47D cells and a highly tumorigenic, more invasive T47Dco subclone. Inmmunoblotting with an affinity purified antibody directed against a synthetic peptide recognizes the 67LR in these cells. 67LR expression in the T47Dco subclone is 5,5-fold higher than in their parental T47D cells. Treatment of T47D cells with 1 nM of the synthetic progestin R5020 results in a 4-fold increase in 67LR protein expression. Estrogen also induced 67LR expression, but only by 1.5-fold. The progestin-stimulated expression of the 67LR correlates with a 4.3-fold increase in attachment of T47D cells to laminin. A monoclonal antibody, mAb 13, directed against β1 integrin, completely blocks the attachment of T47D cells to fibronectin, only partially inhibits the attachment of T47D cells to laminin, and appears not to affect the progestin-stimulated laminin attachment of T47D cells. A new antiprogestin, ZK 112.993, significantly inhibits both progestin-stimulated 67LR expression and the increased attachment to laminin. These results suggest a possible role for progestin in mediating one of the multiple events thought to be important in metastasis of steroid receptor positive human breast cancer cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Liotta LA, Rao CN and Barsky SH, 1983, Tumor invasion and the extracellular matrix. Laboratory Investigations, 49, 639–649.

    Google Scholar 

  2. Liotta LA, 1986, Tumor invasion and metastasesrole of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Research, 46, 1–7.

    Google Scholar 

  3. Poste G and Fidler I, 1980, The pathogenesis of cancer metastases. Nature, 283, 139–146.

    Google Scholar 

  4. Hunt G, 1989, The role of laminin in cancer invasion and metastasis. Experimental and Cellular Biology, 57(3), 165–176.

    Google Scholar 

  5. Castronovo V, Taraboletti G, Liotta LA and Sobel ME, 1989, Modulation of laminin receptor expression by estrogen and progestins in human breast cancer cell lines. Journal of the National Cancer Institute, 81, 781–786.

    Google Scholar 

  6. Timpl R, Rhode H and Robey PG, 1979, Laminin: a glycoprotein from basement membranes. Journal of Biological Chemistry, 254, 9933–9941.

    Google Scholar 

  7. Albelda SM and Buck CA, 1990, Integrins and other cell adhesion molecules. FASEB Journal, 4, 2868–2880.

    Google Scholar 

  8. Kleinman HK, Ogle RC, Cannon FG, Little CD, Sweeney TM and Luckenbill-Edds L, 1988, Laminin receptors for neurite formation. Proceedings of the National Academy of Sciences, USA, 85, 1282–1286.

    Google Scholar 

  9. Clement B, Segui-Real B, Savagner P,Kleinman HK and Yamada Y, 1990, Hepatocyte attachment to laminin is mediated through multiple receptors. Journal of Cell Biology, 110, 185–192.

    Google Scholar 

  10. Smalheiser NR and Schwartz NB, 1987, Cranin: a laminin-binding protein of cell membranes. Proceedings of the National Academy of Sciences, USA, 84, 6457–6461.

    Google Scholar 

  11. Clegg DO, Helder JC, Hann BC and Reichardt LF, 1988, Amino acid sequence and distribution of mRNA encoding a major skeletal muscle laminin binding protein: an extracellular matrix-associated protein with an unusual COOH-terminal polyaspartate domain. Journal of Cell Biology, 107, 699–705.

    Google Scholar 

  12. Hall DE, Frazer KA, Hann BC and Reichardt LF, 1988, Isolation and characterization of a lamininbinding protein from rat and chick muscle. Journal of Cell Biology, 107, 687–697.

    Google Scholar 

  13. Rao CN, Barsky SH, Terranova VP and Liotta LA, 1983, Isolation of a tumor cell laminin receptor. Biochemical and Biophysical Research Communications, 111, 804–808.

    Google Scholar 

  14. Yow H, Wong JM, Chen HS, Lee C, Steele GD and Chen LB, 1988, Increased mRNA expression of a laminin-binding protein in human colon carci noma: complete sequence of a full-length cDNA encoding the protein. Proceedings of the National Academy of Sciences, USA, 85, 6394–6398.

    Google Scholar 

  15. Terranova VP, Rao CN, Kalebic T, Margulies IMK and Liotta LA, 1983, Laminin receptor on human breast carcinoma cells. Proceedings of the National Academy of Sciences, USA, 80, 444–448.

    Google Scholar 

  16. Rao CN, Castronovo V, Schmitt MC, Wewer UM, Claysmith AP, Liotta LA and Sobel ME, 1989, Evidence for a precursor of the high-affinity metas tasis-associated murine laminin receptor. Biochemistry, 28, 7476–7486.

    Google Scholar 

  17. Horan HP, Thor A, Schlom J, Rao CN and Liotta L, 1985, Expression of laminin receptor in normal and carcinomatous human tissues as defined by a monoclonal antibody. Cancer Research, 45, 2713–2719.

    Google Scholar 

  18. Malinoff H and Wicha MS, 1983, Isolation of a cell surface receptor protein for laminin from murine fibrosarcoma cells. Journal of Cell Biology, 96, 1475–1480.

    Google Scholar 

  19. Alino SF, Unda FJ and Perez-Yarza G, 1990, Laminin surface binding sites and metastatic potential of 3LL tumor cells, increased by indomethacin. Biochemical and Biophysical Research Communications, 167, 731–738.

    Google Scholar 

  20. Castronovo V, Colin C, Claysmith AP, Chen PHS, Lifrange E, Lambotte R, Krutzsch H, Liotta LA and Sobel ME, 1990, Immunodetection of the metastasis-associated laminin receptor in human breast cancer cells obtained by fine-needle aspiration biopsy. American Journal of Pathology, 137, 1373–1381.

    Google Scholar 

  21. Cioce V, Castronovo V, Shmookler MB, Garbisa S, Grigione WF, Liotta LA and Sobel ME, 1991, Increased expression of the laminin receptor in hu man colon cancer. Journal of the National Cancer Institute, 83, 29–36.

    Google Scholar 

  22. Dickson RB and Lippman ME, 1987, Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrine Reviews, 8, 29–43.

    Google Scholar 

  23. Clarke CL and Sutherland RL, 1990, Progestin regulation of cellular proliferation. Endocrine Reviews, 11, 266–301.

    Google Scholar 

  24. Vignon F, Bardon S, Chalbos D and Rochefort H, 1983, Antiestrogenic effect of R5020, a synthetic progestin, in human breast cancer cells in culture. Journal of Clinical Endocrinology and Metabolism, 56, 1124–1130.

    Google Scholar 

  25. Murphy LJ and Dotzlaw H, 1989, Endogenous growth factor expression in T47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiprogestins. Cancer Research, 49, 599–604.

    Google Scholar 

  26. Poulin R, Dufour JM and Labrie F, 1989, Progestin inhibition of estrogen-dependent proliferation in ZR-75–1 human breast cancer cells: antagonism by insulin. Breast Cancer Research and Treatment, 13, 265–276.

    Google Scholar 

  27. Hissom JR and Moore MR, 1987, Progestin effects on growth in the human breast cancer cell line T47D: possible therapeutic implications. Biochemical and Biophysical Research Communications, 145, 706–711.

    Google Scholar 

  28. Hissom JR, Bowden RT and Moore MR, 1989, Effects of progestins, estrogens and anti-hormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D. Endocrinology, 125, 418–423.

    Google Scholar 

  29. Manni A, Wright C and Buck H, 1991, Role of insulin-like growth factor in the multihormonal control of MCF-7 breast cancer growth in soft agar. Proceedings of the American Association of Cancer Research, 32, 1237.

    Google Scholar 

  30. Papa V, Reese CC, Brunetti A, Vigneri R, Siiteri PK and Goldfine ID, 1990, Progestins increase insulin receptor content and insulin stimulation of growth in human breast carcinoma cells. Cancer Research, 50, 7858–7863.

    Google Scholar 

  31. Schatz RW, Soto AM and Sonnenschein C, 1985, Effects of interaction between estradiol and progesterone on the proliferation of cloned breast tumor cells (MCF-7 and T47D). Journal of Cell Physiology, 124, 386–390.

    Google Scholar 

  32. Albini A, Graf JG, Kitten GT, Kleinman HK, Martin GR, Veillette A and Lippman ME, 1986, 17\-Estradiol regulates and v-Ha-ras transfection constitutively enhances MCF-7 breast cancer cell interactions with basement membrane. Proceedings of the National Academy of Sciences, USA, 83, 8182–8186.

    Google Scholar 

  33. Thompson EW, Reich R, Shima TB, Albini A, Graf J, Martin GR, Dickson RB and Lippman ME, 1988, Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens. Cancer Research, 48, 6764–6768.

    Google Scholar 

  34. Castronovo V and Sobel ME, 1990, Laminin and fibronectin increase the steady state level of the 67 kD high affinity metastasis-associated laminin receptor mRNA in human cancer cells. Biochemical and Biophysical Research Communications, 168, 1110–1117.

    Google Scholar 

  35. Kanemoto T, Reich R, Royce L, Greatorex D, Adler SH, Shiraishi N, Martin GR, Yamada Y and Kleinman HK, 1990, Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production.Proceedings of the National Academy of Sciences, USA, 87, 2279–2283.

    Google Scholar 

  36. Michna H, Schneider MR, Nishino Y and El Etreby MF, 1989, The antitumor mechanism of progesterone antagonists is a receptor mediated antipro liferative effect by induction of terminal cell death. Journal of Steroid Biochemistry, 34, 447–453.

    Google Scholar 

  37. Sugarman BJ, Aggarwall BB and Hass PE, 1985, Recombinant human tumor necrosis factor-α: effects on proliferation of normal and transformed cells in vivo. Science, 230, 943–945.

    Google Scholar 

  38. Shi YE and Yager JD, 1990, Regulation of rat hepatocyte epidermal growth factor receptor by the liver tumor promoter ethinyl estradiol. Carcinogenesis, 11, 1103–1109.

    Google Scholar 

  39. Kamps MP and Sefton BM, 1988, Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros and v-erb-B oncogenic tryosine protein kinases utilizing antisera against phosphotyrosine. Oncogene, 2, 305–315.

    Google Scholar 

  40. Mukku VR and Stancel GM, 1985, Regulation of epidermal growth factor receptor by estrogen. Journal of Biological Chemistry, 260, 9820–9824.

    Google Scholar 

  41. Kleinbaum DG and Kupper LL. Applied Regression Analysis and Other Multivariable Methods. N. Scituate, MA: Duxbury Press, 1987.

    Google Scholar 

  42. Ramos DM, Berston ED and Kramer RH, 1990, Analysis of integrin receptor for laminin and type IV collogen on metastatic B16 melanoma cells. Cancer Research, 50, 728–734.

    Google Scholar 

  43. Yamada KM, Kennedy DW, Yamada SS, Gralnick H, Chen WT and Akiyama SK, 1990, Monoclonal antibody and synthetic peptide inhibitors of human tumor cell migration. Cancer Research, 50, 4485–4496.

    Google Scholar 

  44. Bryant G, Haberern C, Rao CN and Liotta LA, 1986, Butyrate induced reduction of tumor cell laminin receptors. Cancer Research, 46, 807–811.

    Google Scholar 

  45. Yoon PS, Boxer LA, Mayo LA, Yang AY and Wicha MS, 1987, Human neutrophil laminin receptors: activation-dependent receptor expression. Journal of Immunology, 138, 259–265.

    Google Scholar 

  46. Castronovo V, Claysmith AP, Barker KT, Cioce V, Krutzsch H and Sobel ME, 1991, Biosynthesis of the 67 kDa high affinity laminin receptor. Biochemical and Biophysical Research Communications, 177, 177–183.

    Google Scholar 

  47. Castronovo V, Taraboletti G and Sobel ME, 1991, Functional domains of the 67-kDa laminin receptor precursor. Journal of Biological Chemistry, 266, 20440–20446.

    Google Scholar 

  48. Rescan PY, Clement B, Yamada Y, Glaise D, Segui-Real B, Guguen-Guillouzo C and Guillouzo A, 1991, Expression of laminin and its receptor LBP-32 in human and rat hepatoma cells. Hepatology, 13, 289–296.

    Google Scholar 

  49. King RJB and Whitehead MI, 1986, Assessment of the potency of orally administered progestins in women. Fertility and Sterility, 46, 1062–1066.

    Google Scholar 

  50. Schneider MR, Michna H, Nishino Y and Etreby MFE, 1989, Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat. European Journal of Cancer and Clinical Oncology, 25, 691–701.

    Google Scholar 

  51. Welsch CW, 1985, Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Research, 45, 3415–3443.

    Google Scholar 

  52. Robinson SP and Jordan VC, 1987, Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethylbenzanthracene-induced rat mam mary carcinoma model Cancer Research, 47, 5386–5390.

    Google Scholar 

  53. Asselin J, Kelly PA, Caron MG and Labrie F, 1977, Control of hormone receptor levels and growth of 7,12-dimethylbenzanthracene induced mammary tumors by estrogens, progesterones and prolactin. Endocrinology, 101, 666–671.

    Google Scholar 

  54. Anderson TJ, Battersby S, King RJB, McPherson K and Going JJ, 1989, Oral contraceptive use influences resting breast proliferation. Human Pathology, 20, 1139–1144

    Google Scholar 

  55. Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M and Howell A, 1988, The effect of age and menstrual cycle upon proliferative activity of the normal human breast. British Journal of Cancer, 58, 163–170.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vincent T. Lombardi Cancer Research Center, Georgetown University Medical Center, Washington, USA

    Yuenian E. Shi, Jeff Torri, Lynn Yieh, Marc E. Lippman, Robert B. Dickson & Erik W. Thompson

  2. Laboratory of Pathology, National Cancer Institute, Bethesda, MD, USA

    Mark E. Sobel

  3. Laboratory of Developmental Biology, National Institute for Dental Research, National Institute of Health, Bethesda, MD, USA

    Yoshihiko Yamada

Authors
  1. Yuenian E. Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeff Torri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lynn Yieh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mark E. Sobel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshihiko Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marc E. Lippman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert B. Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Erik W. Thompson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shi, Y.E., Torri, J., Yieh, L. et al. Expression of 67 kDa laminin receptor in human breast cancer cells: regulation by progestins. Clin Exp Metast 11, 251–261 (1993). https://doi.org/10.1007/BF00121168

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00121168

Keywords

Search

Navigation